Skadden is representing Upsher-Smith Laboratories Inc. in its acquisition of Proximagen Group Plc, a European biotechnology company, announced on June 13. The deal is worth up to approximately $550 million.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates